This integrated process statement relates to the document 'Medicines optimisation: key therapeutic topics' (hereafter referred to as key therapeutic topics). It has been produced to explain how key therapeutic topics are developed. It provides an overview of the key process and principles, and describes all stages of the development of key therapeutic topics. These procedures are designed to ensure that a robust, quality-assured document is developed in an open, transparent and timely way, with appropriate input from key groups. This process statement uses the NICE Implementation Support Tool process as an overarching guide to the principles of its development.
http://ift.tt/2q4O70B
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Τετάρτη 10 Μαΐου 2017
Medicines Optimisation: Key Therapeutic Topics – Integrated Process Statement [Internet].
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
-
Summary 外阴佩吉特病(VPD)是一种罕见的皮肤疾病,常见于绝经后的白人女性,它会引起外阴周围的皮肤瘙痒或灼烧。这种疾病有不同的类型,并且在过去,所有类型的 VPD 都与乳腺、肠道和泌尿系统的恶性肿瘤(如癌症)有关。这项来自荷兰的研究着眼于皮肤非侵入性 VPD, 其中在诊...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου